Selection of hepatitis B virus variants with aminoacid substitutions inside the core antigen during interferon-alpha therapy (Q39376578)

11 September 2017

Selection of hepatitis B virus variants with aminoacid substitutions inside the core antigen during interferon-alpha therapy (English)

1 reference

11 September 2017

1 reference

5

Gerken G

1 reference

11 September 2017

2

Protzer U

1 reference

11 September 2017

Radecke K

1

1 reference

11 September 2017

Trippler M

series ordinal

3

1 reference

11 September 2017

Meyer Zum Büschenfelde KH

series ordinal

4

1 reference

11 September 2017

1 December 2000

1 reference

Journal of Medical Virology

11 September 2017

1 reference

11 September 2017

62

1 reference

11 September 2017

4

1 reference

11 September 2017

479-486

1 reference

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

11 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Emergence of hepatitis B virus S gene mutant in a liver transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Vaccine-induced escape mutant of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Viral genetic variation: hepatitis B virus as a clinical example

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Hepatitis B e antigen negative chronic active hepatitis: hepatitis B virus core mutations occur predominantly in known antigenic determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Hepatitis B virus immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Novel pre-C/C gene mutants of hepatitis B virus in chronic active hepatitis: naturally occurring escape mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Mechanisms of immune escape in viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200012%2962%3A4%3C479%3A%3AAID-JMV13%3E3.0.CO%3B2-M

10.1002/1096-9071(200012)62:4<479::AID-JMV13>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

release_4hli47toxfgsjigv2rmjy6k45a

11 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4hli47toxfgsjigv2rmjy6k45a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference